human-factors

(5)
Company
The Realtime Group makes the awkward parts work
Health · Hardware · Enterprise

The Realtime Group makes the awkward parts work

A medical device can work perfectly on a bench and still bewilder its user. This Plano engineering firm builds for the messier test: people, production, and proof.

medical-device-engineering · human-factorsRead →
Company
Emergo by UL and the last mile of medical invention
Health · Enterprise · Saas

Emergo by UL and the last mile of medical invention

A medical device can work perfectly and still be difficult to use, register or sell. Emergo by UL has built a business around those awkward final steps - and the years of compliance that follow.

medical-devices · regulatory-consultingRead →
Company
Cambridge Design Partnership gets past “almost works”
Health · Hardware · Consumer

Cambridge Design Partnership gets past “almost works”

A prototype can impress a room and still be impossible to manufacture. Cambridge Design Partnership has built a business in that awkward gap, fixing everything from diagnostic instruments to the feel of a kitchen knife.

product-development · medical-devicesRead →
Company
Five Engineers, Twenty-Five Pounds and a Workshop for Medicine
Health · Hardware · Enterprise

Five Engineers, Twenty-Five Pounds and a Workshop for Medicine

Team Consulting nearly disappeared before it found its lane. Four decades later, its employee-owners build the unglamorous machinery behind better injections, longer-lived transplant organs and an ear clinic that fits in a hand.

medical-device-development · medtech-consultingRead →
Company
Luna Diabetes
Health · Hardware · Consumer

Luna Diabetes

Luna Diabetes (Luna Health Inc.) is a San Diego medical device company building the first automated insulin delivery system designed for the more than 90% of insulin-requiring people who dose with an insulin pen rather than a full-time pump. Its flagship product, Luna, pairs what the company calls the world's smallest insulin patch pump with a fully closed-loop algorithm to automate micro-doses of rapid-acting insulin overnight, when most of the glucose benefit from pump therapy occurs. Founded in 2020 by diabetes-industry veterans John Sjolund, Jon Brilliant and Sean Saint, the company raised a $23.6M Series A in August 2025 and is running a pivotal clinical trial using Time in Range as its primary endpoint.

diabetes · insulin-deliveryRead →